Please try another search
© Reuters. FILE PHOTO: A trader works on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., July 26, 2023. REUTERS/Brendan McDermid/File Photo
By Carolina Mandl and Bansari Mayur Kamdar
(Reuters) - All three major U.S. indexes ended the week with gains, after a slew of Big Tech earnings, economic data and central bank announcements boosted investor confidence in a soft landing for the U.S. economy.
U.S. annual inflation slowed considerably in June, likely pushing the Federal Reserve closer to ending its fastest interest rate hiking cycle since the 1980s, data showed on Friday.
In the 12 months through June, the PCE price index advanced 3.0%. That was the smallest annual gain since March 2021 and followed a 3.8% rise in May.
"You put all that together and you end up with this idea that this Goldilocks economy might continue for a little while, with inflation clearly coming down," said Scott Ladner, Chief Investment Officer at Horizon Investments.
The Dow Jones Industrial Average rose 176.37 points, or 0.5%, to 35,459.09, the S&P 500 gained 44.76 points, or 0.99%, to 4,582.17 and the Nasdaq Composite added 266.55 points, or 1.9%, to 14,316.66.
"People are more sanguine about the possibility of inflation being under control and the economy avoiding a recession," said Win Murray, director of research at asset manager Diamond Hill.
For the week, the Nasdaq climbed 2.02%, while the S&P rose 1.01%, and the Dow gained 0.66%. The gains gave the S&P 500 its highest close since April 4, 2022.
Volume on U.S. exchanges was 10.10 billion shares, compared with the 10.45 billion average for the full session over the last 20 trading days.
On Wednesday, Federal Reserve Chair Jerome Powell said the Fed was not forecasting a recession and did not rule out another rate hike, saying it would follow future economic data.
To complete a week of encouraging signs, more than half of the firms listed on the S&P 500 have reported second quarter earnings as of Friday, out of which 78.7% have surpassed analyst expectations, according to Refinitiv data.
Barclays (LON:BARC) said investors flocked to equities this week, with inflows of $10 billion to U.S.-listed stocks, according to a note to clients.
Most of the 11 major S&P 500 sectors posted gains, led by communications services, which gained 2.3% as big tech companies kept an upward trend after announcing earnings earlier this week. On the earnings front, Intel (NASDAQ:INTC)'s results and forecast pointed to an improving PC market, sending the chipmaker's shares up 6.60%. Peers Nvidia (NASDAQ:NVDA) and Marvell (NASDAQ:MRVL) Technology also gained 1.85% and 1.60% respectively. On Thursday, the blue-chip Dow snapped its longest winning streak since 1987 as U.S. Treasury yields pressured stocks after news that the Bank of Japan will allow long-term interest rates to rise. The Bank of Japan made its yield curve control policy more flexible and loosened its defense of a long-term interest rate cap, in moves seen by investors as a prelude to an eventual shift away from massive monetary stimulus. The yield on the U.S. 10-year note slipped from 4% hit in the previous session, lifting megacap growth and technology stocks sharply higher.
Procter & Gamble (NYSE:PG) climbed 2.83% after the consumer behemoth beat analysts' estimates for quarterly sales.Ford Motor (NYSE:F) shed 3.42% after Chief Executive Jim Farley outlined a change in the automaker's product strategy, slowing the ramp-up of money-losing electric vehicles.Enphase Energy (NASDAQ:ENPH) fell 7.48% after the solar inverter maker's third-quarter revenue forecast missed expectations, while Juniper Networks (NYSE:JNPR) tumbled 6.94% as the network operator forecast third-quarter revenue below market estimates.
Exxon Mobil (NYSE:XOM) fell 1.19% after the oil giant posted a 56% slump in quarterly profit, while peer Chevron (NYSE:CVX) shed 0.50% after forecasting annual production near the low end of its previously estimated range.
Reata Pharmaceuticals (NASDAQ:RETA) surged 54.02% after Biogen (NASDAQ:BIIB) agreed to buy the rare disease drugmaker for nearly $6.5 billion.
Advancing issues outnumbered declining ones on the NYSE by a 2.64-to-1 ratio; on Nasdaq, a 2.81-to-1 ratio favored advancers.
The S&P 500 posted 27 new 52-week highs and two new lows; the Nasdaq Composite recorded 83 new highs and 84 new lows.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.